Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in-vivo study

PURPOSE: Treatment of chronic osteomyelitis (bone infection) remains a clinical challenge. Our previous study had demonstrated that NEMO-binding domain (NBD) peptide effectively ameliorates the inhibition of osteoblast differentiation by TNF-α in vitro. In this work, NBD peptide was evaluated in viv...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chang-Peng, Chen, Ya, Sun, Hong-Tao, Cui, Zhuang, Yang, Ya-Jun, Huang, Lei, Yu, Bin, Wang, Fa-Zheng, Yang, Qing-Po, Qi, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864959/
https://www.ncbi.nlm.nih.gov/pubmed/31832182
http://dx.doi.org/10.1186/s13756-019-0627-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864959/
https://www.ncbi.nlm.nih.gov/pubmed/31832182
http://dx.doi.org/10.1186/s13756-019-0627-y

Ejemplares similares